Simon Gronowitz

415 total citations
20 papers, 323 citations indexed

About

Simon Gronowitz is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Simon Gronowitz has authored 20 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 9 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Simon Gronowitz's work include Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Simon Gronowitz is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Simon Gronowitz collaborates with scholars based in Sweden, Israel and Germany. Simon Gronowitz's co-authors include Clas F. R. Källander, Hans Hagberg, Benjamin Nisman, Tamar Peretz, A. Killander, Bengt Glimelius, Christer Sundström, Tamar Hamburger, Tanir M. Allweis and Hovav Nechushtan and has published in prestigious journals such as Annals of Neurology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Simon Gronowitz

20 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Gronowitz Sweden 12 150 143 85 79 77 20 323
M Paquin United States 7 75 0.5× 70 0.5× 82 1.0× 84 1.1× 69 0.9× 7 370
Todd S. Laughlin United States 13 45 0.3× 104 0.7× 91 1.1× 77 1.0× 51 0.7× 18 361
Amanda Psyrri United States 8 55 0.4× 143 1.0× 101 1.2× 82 1.0× 26 0.3× 12 391
G. Ott Germany 13 93 0.6× 155 1.1× 52 0.6× 37 0.5× 198 2.6× 25 421
Jonathan Weintraub Switzerland 10 77 0.5× 107 0.7× 53 0.6× 19 0.2× 61 0.8× 16 374
K John United States 11 68 0.5× 100 0.7× 32 0.4× 53 0.7× 89 1.2× 16 374
Mary Lowery Nordberg United States 9 77 0.5× 127 0.9× 21 0.2× 72 0.9× 76 1.0× 26 390
H M Golomb United States 11 112 0.7× 94 0.7× 28 0.3× 89 1.1× 87 1.1× 21 392
Alessandra Viglio Italy 12 84 0.6× 230 1.6× 97 1.1× 34 0.4× 216 2.8× 28 478
Tuula Lehtinen Finland 14 73 0.5× 201 1.4× 67 0.8× 39 0.5× 238 3.1× 26 464

Countries citing papers authored by Simon Gronowitz

Since Specialization
Citations

This map shows the geographic impact of Simon Gronowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Gronowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Gronowitz more than expected).

Fields of papers citing papers by Simon Gronowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Gronowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Gronowitz. The network helps show where Simon Gronowitz may publish in the future.

Co-authorship network of co-authors of Simon Gronowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Gronowitz. A scholar is included among the top collaborators of Simon Gronowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Gronowitz. Simon Gronowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Felix, Klaus, Ulf Hinz, Sophie Dobiasch, et al.. (2017). Preoperative Serum Thymidine Kinase Activity as Novel Monitoring, Prognostic, and Predictive Biomarker in Pancreatic Cancer. Pancreas. 47(1). 72–79. 8 indexed citations
2.
3.
Nisman, Benjamin, Hovav Nechushtan, Haim Biran, et al.. (2014). Serum Thymidine Kinase 1 Activity in the Prognosis and Monitoring of Chemotherapy in Lung Cancer Patients: A Brief Report. Journal of Thoracic Oncology. 9(10). 1568–1572. 21 indexed citations
4.
Nisman, Benjamin, Luna Kadouri, Tanir M. Allweis, et al.. (2013). Increased Proliferative Background in Healthy Women with BRCA1/2 Haploinsufficiency Is Associated with High Risk for Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 22(11). 2110–2115. 7 indexed citations
5.
Sauerbrei, Andreas, K. Bohn, Andreas Henke, et al.. (2012). Significance of amino acid substitutions in the thymidine kinase gene of herpes simplex virus type 1 for resistance. Antiviral Research. 96(2). 105–107. 17 indexed citations
6.
Sauerbrei, Andreas, et al.. (2012). Screening of herpes simplex virus type 1 isolates for acyclovir resistance using DiviTum® assay. Journal of Virological Methods. 188(1-2). 70–72. 10 indexed citations
7.
Nisman, Benjamin, Tanir M. Allweis, Luna Kadouri, et al.. (2012). Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patients. Clinical Chemistry and Laboratory Medicine (CCLM). 51(2). 439–447. 30 indexed citations
8.
Gronowitz, Simon, et al.. (2012). Total Cell Division The Ultimate Biomarker for Personalized Medicine in Cancer? Updated Technology and Novel Clinical Results. Annals of Oncology. 23. ix88–ix88. 1 indexed citations
9.
Nisman, Benjamin, Vladimir Yutkin, Hovav Nechushtan, et al.. (2010). Circulating Tumor M2 Pyruvate Kinase and Thymidine Kinase 1 Are Potential Predictors for Disease Recurrence in Renal Cell Carcinoma After Nephrectomy. Urology. 76(2). 513.e1–513.e6. 28 indexed citations
10.
Nisman, Benjamin, Tanir M. Allweis, Luna Kaduri, et al.. (2010). Serum thymidine kinase 1 activity in breast cancer. Cancer Biomarkers. 7(2). 65–72. 34 indexed citations
11.
Wolday, Dawit, et al.. (2005). Alternative Approach to Blood Screening Using the ExaVir Reverse Transcriptase Activity Assay. Current HIV Research. 3(4). 371–376. 5 indexed citations
12.
Letocha, Henry, et al.. (1996). Deoxythymidine kinase in the staging of prostatic adenocarcinoma. The Prostate. 29(1). 15–19. 8 indexed citations
13.
Enblad, Gunilla, Christer Sundström, Simon Gronowitz, & Bengt Glimelius. (1995). Serum levels of interleukin-2 receptor (CD 25) in patients with Hodgkin's disease, with special reference to age and prognosis. Annals of Oncology. 6(1). 65–70. 12 indexed citations
14.
Svenningsson, Anders, Jan Lycke, Bo Svennerholm, Simon Gronowitz, & Oluf Andersen. (1992). No evidence for spumavirus or oncovirus infection in relapsing–remitting multiple sclerosis. Annals of Neurology. 32(5). 711–714. 11 indexed citations
15.
Hagberg, Hans, Bengt Glimelius, Simon Gronowitz, et al.. (1989). Serum thymidine kinase in hairy cell leukemia before and during treatment with alpha interferon.. PubMed. 73(5). 365–9. 1 indexed citations
16.
Persson, Lennart, Simon Gronowitz, & Clas F. R. Källander. (1986). Thymidine kinase in extracts of human brain tumours. Acta Neurochirurgica. 80(3-4). 123–127. 13 indexed citations
17.
Eriksson, Barbro, Hans Hagberg, Bengt Glimelius, et al.. (1985). Serum Thymidine Kinase as a Prognostic Marker in Hodgkin's Disease. Acta Radiologica Oncology. 24(2). 167–171. 28 indexed citations
18.
Hagberg, Hans, Simon Gronowitz, A. Killander, et al.. (1984). Serum thymidine kinase in acute leukaemia. British Journal of Cancer. 49(4). 537–540. 32 indexed citations
19.
Hagberg, Hans, Simon Gronowitz, A. Killander, & Clas F. R. Källander. (1984). Serum Thymidine Kinase in Vitamin B12Deficiency. Scandinavian Journal of Haematology. 32(1). 41–45. 20 indexed citations
20.
Hagberg, Hans, et al.. (1984). Biochemical markers in non‐Hodgkin's lymphoma stages III and IV and prognosis: A multivariate analysis. Scandinavian Journal of Haematology. 33(1). 59–67. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Paquin Breakdown of academic impact, for papers by Todd S. Laughlin Breakdown of academic impact, for papers by Amanda Psyrri Breakdown of academic impact, for papers by G. Ott Breakdown of academic impact, for papers by Jonathan Weintraub Breakdown of academic impact, for papers by K John Breakdown of academic impact, for papers by Mary Lowery Nordberg Breakdown of academic impact, for papers by H M Golomb Breakdown of academic impact, for papers by Alessandra Viglio Breakdown of academic impact, for papers by Tuula Lehtinen
Rankless by CCL
2026